Conley AP - Search Results

1

Synergistic induction of apoptosis by the Bcl-2 inhibitor ABT-737 and imatinib mesylate in gastrointestinal stromal tumor cells.

Reynoso D, Nolden LK, Yang D, Dumont SN, Conley AP, Dumont AG, Zhou K, Duensing A, Trent JC. Reynoso D, et al. Among authors: conley ap. Mol Oncol. 2011 Feb;5(1):93-104. doi: 10.1016/j.molonc.2010.10.003. Epub 2010 Oct 16. Mol Oncol. 2011. PMID: 21115411 Free PMC article.

2

Recent progress in the genomics of soft tissue sarcomas.

Conley AP, Trent J, Zhang W. Conley AP, et al. Curr Opin Oncol. 2008 Jul;20(4):395-9. doi: 10.1097/CCO.0b013e328302edc0. Curr Opin Oncol. 2008. PMID: 18525334 Review.

3

Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor.

Wang WL, Conley A, Reynoso D, Nolden L, Lazar AJ, George S, Trent JC. Wang WL, et al. Cancer Chemother Pharmacol. 2011 Jan;67 Suppl 1:S15-24. doi: 10.1007/s00280-010-1513-8. Epub 2010 Dec 24. Cancer Chemother Pharmacol. 2011. PMID: 21181476 Review.

4

The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis.

Park MS, Ravi V, Conley A, Patel SR, Trent JC, Lev DC, Lazar AJ, Wang WL, Benjamin RS, Araujo DM. Park MS, et al. Clin Sarcoma Res. 2013 May 11;3(1):7. doi: 10.1186/2045-3329-3-7. Clin Sarcoma Res. 2013. PMID: 23663788 Free PMC article.

5

Treatment patterns, prescribing decision drivers, and predictors of complete response following disease recurrence in gastrointestinal stromal tumor patients-a chart extract-based approach.

Conley AP, Guerin A, Sasane M, Gauthier G, Schwiep F, Keir CH, Wu EQ. Conley AP, et al. J Gastrointest Cancer. 2014 Dec;45(4):431-40. doi: 10.1007/s12029-014-9600-4. J Gastrointest Cancer. 2014. PMID: 24847952

6

Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection.

Guérin A, Sasane M, Keir CH, Gauthier G, Macalalad AR, Wu EQ, Conley AP. Guérin A, et al. Among authors: conley ap. JAMA Oncol. 2015 Sep;1(6):797-805. doi: 10.1001/jamaoncol.2015.2407. JAMA Oncol. 2015. PMID: 26204106

7

Comparison of the long-term risk of recurrence and other clinical outcomes in GIST patients receiving imatinib as adjuvant therapy--a retrospective chart extract-based approach.

Conley AP, Guérin A, Sasane M, Gauthier G, Schwiep F, Keir CH, Wu EQ. Conley AP, et al. J Gastrointest Cancer. 2013 Jun;44(2):190-8. doi: 10.1007/s12029-012-9467-1. J Gastrointest Cancer. 2013. PMID: 23229801 Free PMC article.

8

A comparison between patients with gastrointestinal stromal tumours diagnosed with isolated liver metastases and liver metastases plus sarcomatosis.

de la Fuente SG, Deneve JL, Parsons CM, Zager JS, Conley AP, Gonzalez RJ. de la Fuente SG, et al. Among authors: conley ap. HPB (Oxford). 2013 Sep;15(9):655-60. doi: 10.1111/hpb.12011. Epub 2012 Dec 27. HPB (Oxford). 2013. PMID: 23458233 Free PMC article.

9

Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients.

Schvartsman G, Wagner MJ, Amini B, Zobniw CM, Trinh VA, Barbo AG, Lin HY, Wang WL, Conley AP, Ravi V, Araujo DM, Zarzour MA, Benjamin RS, Patel S, Somaiah N. Schvartsman G, et al. Among authors: conley ap. Sci Rep. 2017 Aug 25;7(1):9519. doi: 10.1038/s41598-017-09132-1. Sci Rep. 2017. PMID: 28842575 Free PMC article.

10

Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology.

El Beaino M, Roszik J, Livingston JA, Wang WL, Lazar AJ, Amini B, Subbiah V, Lewis V, Conley AP. El Beaino M, et al. Among authors: conley ap. Curr Oncol Rep. 2018 Mar 26;20(5):37. doi: 10.1007/s11912-018-0668-z. Curr Oncol Rep. 2018. PMID: 29582189 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters